102
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Placental Histopathologic Findings in the Setting of Prenatally Diagnosed Major Congenital Heart Disease

ORCID Icon, ORCID Icon & ORCID Icon
Pages 922-935 | Received 03 Mar 2023, Accepted 26 Sep 2023, Published online: 11 Oct 2023

References

  • Kwon EJ, Kim YJ. What is fetal programming?: a lifetime health is under the control of in utero health. Obstet Gynecol Sci. 2017;60(6):506–19. doi:10.5468/ogs.2017.60.6.506.
  • Kiserud T, Ebbing C, Kessler J, Rasmussen S. Fetal cardiac output, distribution to the placenta and impact of placental compromise. Ultrasound Obstet Gynecol. 2006;28(2):126–36. doi:10.1002/uog.2832.
  • Linask KK. The heart-placenta axis in the first month of pregnancy: induction and prevention of cardiovascular birth defects. J Pregnancy. 2013;2013:320413. doi:10.1155/2013/320413.
  • Araujo Júnior E, Palma-Dias R, Martins WP, Reidy K, da Silva Costa F. Congenital heart disease and adverse perinatal outcome in fetuses with confirmed isolated single functioning umbilical artery. J Obstet Gynaecol. 2015;35(1):85–7. doi:10.3109/01443615.2014.935720.
  • Maslen CL. Recent advances in placenta-heart interactions. Front Physiol. 2018;9:735. doi:10.3389/fphys.2018.00735.
  • Huhta J, Linask KK. Environmental origins of congenital heart disease: the heart-placenta connection. Semin Fetal Neonatal Med. 2013;18(5):245–50. doi:10.1016/j.siny.2013.05.003.
  • Donofrio MT, Moon-Grady AJ, Hornberger LK, Copel JA, Sklansky MS, Abuhamad A, Cuneo BF, Huhta JC, Jonas RA, Krishnan A, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014;129(21):2183–242. doi:10.1161/01.cir.0000437597.44550.5d.
  • Roescher AM, Timmer A, Erwich JJ, Bos AF. Placental pathology, perinatal death, neonatal outcome, and neurological development: a systematic review. PLoS One. 2014;9(2):e89419. doi:10.1371/journal.pone.0089419.
  • Albalawi A, Brancusi F, Askin F, Ehsanipoor R, Wang J, Burd I, Sekar P. Placental characteristics of fetuses with congenital heart disease. J Ultrasound Med. 2017;36(5):965–72. doi:10.7863/ultra.16.04023.
  • Matthiesen NB, Henriksen TB, Gaynor JW, Agergaard P, Bach CC, Hjortdal VE, Østergaard JR. Congenital heart defects and indices of fetal cerebral growth in a nationwide cohort of 924 422 liveborn infants. Circulation. 2016;133(6):566–75. doi:10.1161/CIRCULATIONAHA.115.019089.
  • Jones HN, Olbrych SK, Smith KL, Cnota JF, Habli M, Ramos-Gonzales O, Owens KJ, Hinton AC, Polzin WJ, Muglia LJ, et al. Hypoplastic left heart syndrome is associated with structural and vascular placental abnormalities and leptin dysregulation. Placenta. 2015;36(10):1078–86. doi:10.1016/j.placenta.2015.08.003.
  • Andescavage N, Yarish A, Donofrio M, Bulas D, Evangelou I, Vezina G, McCarter R, duPlessis A, Limperopoulos C. 3-D volumetric MRI evaluation of the placenta in fetuses with complex congenital heart disease. Placenta. 2015;36(9):1024–30. doi:10.1016/j.placenta.2015.06.013.
  • Zun Z, Zaharchuk G, Andescavage NN, Donofrio MT, Limperopoulos C. Non-invasive placental perfusion imaging in pregnancies complicated by fetal heart disease using velocity-selective arterial spin labeled MRI. Sci Rep. 2017;7(1):16126. doi:10.1038/s41598-017-16461-8.
  • Rychik J, Goff D, McKay E, Mott A, Tian Z, Licht DJ, Gaynor JW. Characterization of the placenta in the newborn with congenital heart disease: distinctions based on type of cardiac malformation. Pediatr Cardiol. 2018;39(6):1165–71. doi:10.1007/s00246-018-1876-x.
  • Miremberg H, Gindes L, Schreiber L, Raucher Sternfeld A, Bar J, Kovo M. The association between severe fetal congenital heart defects and placental vascular malperfusion lesions. Prenat Diagn. 2019;39(11):962–7. doi:10.1002/pd.5515.
  • O'Hare CB, Mangin-Heimos KS, Gu H, Edmunds M, Bebbington M, Lee CK, He M, Ortinau CM. Placental delayed villous maturation is associated with fetal congenital heart disease. Am J Obstet Gynecol. 2023;228(2):231.e1–231.e11. doi:10.1016/j.ajog.2022.08.013.
  • Leon RL, Sharma K, Mir IN, Herrera CL, Brown SL, Spong CY, Chalak LF. Placental vascular malperfusion lesions in fetal congenital heart disease. Am J Obstet Gynecol. 2022; 227(4):620.e1–620.e8. doi:10.1016/j.ajog.2022.05.038.
  • Carvalho JS, Mavrides E, Shinebourne EA, Campbell S, Thilaganathan B. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart. 2002;88(4):387–91. doi:10.1136/heart.88.4.387.
  • Di Renzo GC, Luzi G, Cucchia GC, Caserta G, Fusaro P, Perdikaris A, Cosmi EV. The role of Doppler technology in the evaluation of fetal hypoxia. Early Hum Dev. 1992;29(1–3):259–67. doi:10.1016/0378-3782(92)90162-a.
  • Khong TY, Mooney EE, Ariel I, Balmus NC, Boyd TK, Brundler MA, Derricott H, Evans MJ, Faye-Petersen OM, Gillan JE, et al. Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement. Arch Pathol Lab Med. 2016;140(7):698–713. doi:10.5858/arpa.2015-0225-CC.
  • Altshuler G. Chorangiosis. An important placental sign of neonatal morbidity and mortality. Arch Pathol Lab Med. 1984;108(1):71–4. PMID: 6546343.
  • Ernst LM. Color atlas of fetal and neonatal histology. New York: Springer; 2011; pp. 378–405.
  • Serrano MC, Linask KK, Acharya G, Chen J, Han M, Huhta JC. One-time lithium dose in early gestation causes placental and cardiac dysfunction. Am J Obstet Gynecol. 2006;195(6):S210. doi:10.1016/j.ajog.2006.10.756.
  • Serrano M, Han M, Huhta JCL, Lastra R, Garita B, Linask KK. Abstract 3408: folate suppresses Wnt/beta-catenin inhibition of cardiogenesis to protect against induction of congenital heart defects. Circulation. 2008;118(suppl_18):S_419. doi:10.1161/circ.118.suppl_18.S_419.
  • Linask KK, Huhta J. Folate protection from congenital heart defects linked with canonical Wnt signaling and epigenetics. Curr Opin Pediatr. 2010;22(5):561–6. doi:10.1097/MOP.0b013e32833e2723.
  • Redline RW, Ravishankar S. Fetal vascular malperfusion, an update. APMIS. 2018;126(7):561–9. doi:10.1111/apm.12849.
  • Ernst LM. Maternal vascular malperfusion of the placental bed. APMIS. 2018;126(7):551–60. doi:10.1111/apm.12833.
  • Chen KH, Chen LR, Lee YH. The role of preterm placental calcification in high-risk pregnancy as a predictor of poor uteroplacental blood flow and adverse pregnancy outcome. Ultrasound Med Biol. 2012;38(6):1011–8. doi:10.1016/j.ultrasmedbio.2012.02.004.
  • Moran MC, Mulcahy C, Zombori G, Ryan J, Downey P, McAuliffe FM. Placental volume, vasculature and calcification in pregnancies complicated by pre-eclampsia and intra-uterine growth restriction. Eur J Obstet Gynecol Reprod Biol. 2015;195:12–7. doi:10.1016/j.ejogrb.2015.07.023.
  • Jamal A, Moshfeghi M, Moshfeghi S, Mohammadi N, Zarean E, Jahangiri N. Is preterm placental calcification related to adverse maternal and foetal outcome? J Obstet Gynaecol. 2017;37(5):605–9. doi:10.1080/01443615.2017.1285871.
  • Vafaei H, Karimi Z, Akbarzadeh-Jahromi M, Asadian F. Association of placental chorangiosis with pregnancy complication and prenatal outcome: a case-control study. BMC Pregnancy Childbirth. 2021;21(1):99. doi:10.1186/s12884-021-03576-0.
  • Schlatterer SD, Murnick J, Jacobs M, White L, Donofrio MT, Limperopoulos C. Placental pathology and neuroimaging correlates in neonates with congenital heart disease. Sci Rep. 2019;9(1):4137. doi:10.1038/s41598-019-40894-y.
  • Suzuki K, Itoh H, Kimura S, Sugihara K, Yaguchi C, Kobayashi Y, Hirai K, Takeuchi K, Sugimura M, Kanayama N. Chorangiosis and placental oxygenation. Congenit Anom (Kyoto). 2009;49(2):71–6. doi:10.1111/j.1741-4520.2009.00226.x.
  • Stanek J. Placental hypoxic overlap lesions: a clinicoplacental correlation. J Obstet Gynaecol Res. 2015;41(3):358–69. doi:10.1111/jog.12539.
  • Sung DK, Baergen RN. Focal chorangiosis: does it have clinical and pathologic significance? Pediatr Dev Pathol. 2019;22(5):406–9. doi:10.1177/1093526619830866.
  • Spinillo A, Gardella B, Bariselli S, Alfei A, Silini EM, Bello BD. Cerebroplacental Doppler ratio and placental histopathological features in pregnancies complicated by fetal growth restriction. J Perinat Med. 2014;42(3):321–8. doi:10.1515/jpm-2013-0128.
  • Vollgraff Heidweiller-Schreurs CA, De Boer MA, Heymans MW, Schoonmade LJ, Bossuyt PMM, Mol BWJ, De Groot CJM, Bax CJ. Prognostic accuracy of cerebroplacental ratio and middle cerebral artery Doppler for adverse perinatal outcome: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(3):313–22. doi:10.1002/uog.18809.
  • Krebs C, Macara LM, Leiser R, Bowman AW, Greer IA, Kingdom JC. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol. 1996;175(6):1534–42. doi:10.1016/s0002-9378(96)70103-5.
  • Leon R. (a), Mir IN, Herrera CL, Sharma K, Spong CY, Twickler DM, Chalak LF. Neuroplacentology in congenital heart disease: placental connections to neurodevelopmental outcomes. Pediatr Res. 2022;91(4):787–94. doi:10.1038/s41390-021-01521-7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.